- Home
- CBAN vs EBS Comparison
CBAN vs EBS Comparison
Compare CBAN & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBAN | EBS |
|---|---|---|
| Founded | 1975 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 423.6M | 413.3M |
| IPO Year | 1995 | 2006 |
Fundamental Metrics
Financial Performance| Metric | CBAN | EBS |
|---|---|---|
| Price | $22.32 | $7.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 264.9K | ★ 645.2K |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | 16.91 | ★ 125.83 |
| EPS | ★ 0.39 | 0.07 |
| Revenue | N/A | ★ $742,900,000.00 |
| Revenue This Year | $35.41 | $1.29 |
| Revenue Next Year | $4.84 | N/A |
| P/E Ratio | ★ $56.21 | $105.86 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.80 | $6.03 |
| 52 Week High | $22.29 | $14.06 |
Technical Indicators
Market Signals| Indicator | CBAN | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 64.05 | 41.12 |
| Support Level | $19.38 | N/A |
| Resistance Level | $22.29 | $8.59 |
| Average True Range (ATR) | 0.56 | 0.22 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 95.24 | 34.48 |
Price Performance
Historical ComparisonAbout CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.